Kuyucu Tülin, Güçlü Salih Zeki, Saylan Bengü, Demir Cahit, Senol Tuncer, Güner Serdar, Koyuncu Ejder, Ozen Ferit, Oztürk Sezai, Cangül Zeki, Ağanoğlu Semih, Ozkaya Sevket, Ocak Sevilay Ciçek, Akkurt Hüseyin, Intepe Yavuz Selim, Bayrak Merve Gülcan, Güler Tuncay, Bekçi Taha Tahir, Soyyiğit Sadan, Seyfettin Salim, Kula Ozhan, Akbay Makbule Ozlem, Büyükgöze Bengü, Asal Gökhan, Başlilar Seyma, Oztürk Osman
Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
Tuberk Toraks. 2011;59(4):328-39. doi: 10.5578/tt.3268.
Chronic obstructive pulmonary disease (COPD) is a lung disease characterized with limitation of airflow that is not completely reversible, progressive deterioration of airways and systemic inflammation. This study has been planned to determine daily symptom variability of patients, expectations of patient and physicians from treatment and patient profiles. A total of 514 patients with COPD from 25 centers were included in this national, multicenter, cross-sectional observational study. Data regarding demographic features, concomitant diseases, history and treatment of COPD and expectations of patients and physicians were all obtained in a single visit. Mean [standard deviation (SD)] age of the patients was 64.1 (9.5) years; age range was 41-92 years, 50% of the patients were younger than 65 years and 91% were males. Educational level of the patients was at least primary school in 80.2%; and 54.3% (30.4%) of the patients had at least one concomitant disease, particularly a cardiovascular disease. Mean (SD) duration of having COPD was 5.4 (4.6) years. The majority of patients were at moderate (43.2%) and severe (35.0%) COPD stages and one or more exacerbations per year was determined in 71%. Inhaled beta-2 agonists (84.2%), inhaled steroids (76.3%) and inhaled long-acting anti-cholinergics (70.0%) were the most commonly used medications. Dyspnea (99.0%), sputum production (92.8%) and wheezing (90.5%) were the most common symptoms, and symptom variability for dyspnea (41.1%), sputum production (61.0%) and cough (53.5%) were seen the most in the morning hours (p< 0.001). Most commonly affected morning activity was climbing up/down the stairs (point of effect: 6.7), followed by wearing socks/shoes (point of effect: 4.3) and showering/bathing (point of effect: 4.2) by COPD. Major treatment expectations of patients were greater symptomatic relief (82.3%) and greater mobility (70.0%), faster symptomatic relief (61.1%) and improvement in morning activities (59.3%); while major treatment expectations of physicians included increased quality of life (100.0%) and decreased morbidity (96.0%). Quitting smoking was the most commonly recommended (88.3%) and implemented (67.9%) non-drug protective approach aimed at decreasing the frequency of exacerbations. Consequently, our results demonstrate that COPD is not a disease of only the elderly, is an important healthcare issue that often disrupt daily living of the patients due to inadequate disease awareness leading to overlooking of the symptoms by patient and physicians, and that a patient-centered approach based on the living standards, life expectancies and preferences of patients was crucial in patient management.
慢性阻塞性肺疾病(COPD)是一种以气流受限为特征的肺部疾病,气流受限不完全可逆,气道呈进行性恶化并伴有全身炎症。本研究旨在确定患者的每日症状变异性、患者和医生对治疗的期望以及患者概况。这项全国性、多中心、横断面观察性研究纳入了来自25个中心的514例COPD患者。在一次就诊中获取了有关人口统计学特征、合并疾病、COPD病史和治疗情况以及患者和医生期望的数据。患者的平均[标准差(SD)]年龄为64.1(9.5)岁;年龄范围为41 - 92岁,50%的患者年龄小于65岁,91%为男性。80.2%的患者教育水平至少为小学;54.3%(30.4%)的患者至少有一种合并疾病,尤其是心血管疾病。COPD的平均(SD)病程为5.4(4.6)年。大多数患者处于中度(43.2%)和重度(35.0%)COPD阶段,71%的患者每年有一次或多次急性加重。吸入性β - 2激动剂(84.2%)、吸入性糖皮质激素(76.3%)和吸入性长效抗胆碱能药物(70.0%)是最常用的药物。呼吸困难(99.0%)、咳痰(92.8%)和喘息(90.5%)是最常见的症状,其中呼吸困难(41.1%)、咳痰(61.0%)和咳嗽(53.5%)的症状变异性在早晨最为常见(p < 0.001)。受COPD影响最常见的早晨活动是上下楼梯(影响分值:6.7),其次是穿袜子/鞋子(影响分值:4.3)和淋浴/洗澡(影响分值:4.2)。患者对治疗的主要期望是症状得到更大缓解(82.3%)和活动能力增强(70.0%)、症状缓解更快(61.1%)以及早晨活动有所改善(59.3%);而医生对治疗的主要期望包括提高生活质量(100.0%)和降低发病率(96.0%)。戒烟是最常被推荐(88.3%)和实施(67.9%)的旨在减少急性加重频率的非药物预防措施。因此,我们的结果表明,COPD并非仅为老年人的疾病,而是一个重要的医疗保健问题,由于疾病认知不足导致患者和医生忽视症状,常扰乱患者的日常生活,并且基于患者生活水平、预期寿命和偏好的以患者为中心的方法在患者管理中至关重要。